Tamotsu Miwa

Title: Tamotsu Miwa: Innovator in Anti-Allergic Compounds

Introduction

Tamotsu Miwa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit anti-allergic properties. With a total of 5 patents to his name, Miwa's work has the potential to impact the treatment of various allergic diseases.

Latest Patents

Miwa's latest patents include innovative compounds such as tricyclic triazolopyrimidine derivatives. These novel compounds, represented by formula (I), are disclosed along with their physiologically acceptable salts. They demonstrate excellent anti-allergic activity, making them useful for the treatment and prophylaxis of allergic diseases. Another significant patent involves thiazolo[3,2-a][1,2,3]triazolo[4,5-d]pyrimidine, which also showcases compounds with remarkable anti-allergic activity, particularly in oral administration. These compounds are beneficial for treating conditions such as bronchial asthma, allergic gastrointestinal disorders, allergic rhinitis, hay fever, and urticaria.

Career Highlights

Tamotsu Miwa is associated with Daiichi Seiyaku Co., Ltd., a leading pharmaceutical company. His work at the company has been instrumental in advancing research and development in the field of allergy treatments. Miwa's innovative approach and dedication to his work have earned him recognition in the industry.

Collaborations

Miwa has collaborated with notable colleagues, including Shunzo Aibara and Tosaku Miki. These partnerships have contributed to the successful development of his patented compounds and have fostered a collaborative environment for innovation.

Conclusion

Tamotsu Miwa's contributions to the field of anti-allergic compounds highlight his role as a significant inventor in the pharmaceutical industry. His innovative patents and collaborations continue to pave the way for advancements in allergy treatment.